Imcyse to present positive results in EAE model of multiple sclerosis at ECTRIMS 2019
Domain Therapeutics invests in Ermium Therapeutics to develop first-in-class CXCR4 candidate for autoimmune diseases
Yposkesi’s viral vectors used in gene therapy-based clinical trial
PDC*line Pharma welcomes Dr Channa Debruyne to its management team as medical director
TreeFrog Therapeutics receives additional €3M non-dilutive funding to mass-produce clinical-grade cell therapies by 2021
Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098
Imcyse announces changes in management and board, appoints Thomas Taapken as executive chairman
Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate
